Skip to the page

Data / Form D filings / Nymbl Science, Inc.

Nymbl Science, Inc.: Form D filings

Nymbl Science, Inc., a health care company in Denver, CO, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on September 12, 2025, reports $984,057 sold of a $2.4 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2000 S Colorado Blvd, Tower 2, Suite 320, Denver, CO, 80222
Phone
(650) 233-4548
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1781552

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 12, 2025New notice$2,351,745$984,057$1,367,68830Aug 29, 2025sec.gov
Dec 1, 2022New notice$13,000,000$8,752,476$4,247,52423Oct 17, 2022sec.gov
Oct 7, 2020New notice$3,960,000$3,720,000$240,00022Sep 24, 2020sec.gov
Aug 1, 2019Amendment$2,675,000$2,325,000$350,00027Jun 27, 2019sec.gov
Jul 12, 2019New notice$2,675,000$1,970,000$705,00022Jun 27, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas VirdenDirector
Ben WireDirector
Edward LikovichExecutive Officer, Director
Chris SaxmanDirector
Rohit SethDirector
Meghan OliverDirector
David EichlerDirector

Other health care companies in Colorado that filed recently

Every Form D from the week of Sep 8, 2025 · All recent filings in Colorado · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Nymbl Science, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.